Sophie Wang, MD
Dermatopathology · Birmingham, ALNPI 1205396330
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 37.1% of the total. 2025 is the largest year on record at $2,457, more than ten times the $96 reported in 2021.
Across 167 payments — averaging $34.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Galderma Laboratories, L.p.$492
- Incyte Corporation$439
- Novartis$391
- Boehringer Ingelheim$305
- Johnson & Johnson$231
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,725100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $2,122 |
| Galderma Laboratories, L.p. | 11 | $492 |
| Incyte Corporation | 12 | $439 |
| Novartis | 15 | $391 |
| Boehringer Ingelheim | 3 | $305 |
| Johnson & Johnson | 6 | $231 |
| Arcutis Biotherapeutics, Inc. | 12 | $198 |
| Mayne Pharma Commercial LLC | 13 | $150 |
| Dermavant Sciences, Inc. | 2 | $150 |
| Regeneron Healthcare Solutions, Inc. | 2 | $150 |
| Lilly USA, LLC | 2 | $142 |
| E.r. Squibb & Sons, L.L.C. | 3 | $137 |
| Krystal Biotech Inc | 1 | $125 |
| Organogenesis Inc. | 1 | $120 |
| Sanofi | 2 | $116 |
| Biofrontera Inc. | 3 | $56 |
| Organon | 5 | $55 |
| Amgen | 3 | $50 |
| Astellas Pharma US Inc | 2 | $50 |
| Paratek Pharmaceuticals, Inc. | 3 | $44 |
| LEO Pharma Inc. | 2 | $39 |
| Sun Pharmaceutical Industries Inc. | 2 | $38 |
| Botanix SB Inc | 2 | $36 |
| Pfizer | 1 | $29 |
| Journey Medical Corporation | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| UCB, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few dermatopathology providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 14 | $175 |
| Mupirocin | 16 | $118 |
| Triamcinolone Acetonide | 14 | $80 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Birmingham
- Gina JohnsonBirmingham$816
- Edward FultonBirmingham$243
- Anne BussianBirmingham$221
- James ElderBirmingham$160
- Alexander WongBirmingham$97
- Julie GibbsBirmingham$87
- Deborah SandersBirmingham$76
- James BushBirmingham$62
- Molly BouldinBirmingham$19
- James LyonsDothan$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.